419 related articles for article (PubMed ID: 16099624)
81. Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen beta-lactam antibiotics.
Liñares J; Perez JL; Garau J; Murgui L; Martín R
J Antimicrob Chemother; 1984 Apr; 13(4):353-9. PubMed ID: 6609919
[TBL] [Abstract][Full Text] [Related]
82. Grepafloxacin against penicillin-resistant pneumococci in the rabbit meningitis model.
Gerber CM; Tovar L; Cottagnoud M; Neftel KA; Täuber MG; Cottagnoud P
J Antimicrob Chemother; 2000 Aug; 46(2):249-53. PubMed ID: 10933648
[TBL] [Abstract][Full Text] [Related]
83. Ceftriaxone compared with a combination of ampicillin and chloramphenicol in the treatment of bacterial meningitis in adults.
Girgis NI; Abu el Ella AH; Farid Z; Woody JN; Lissner C
Drugs Exp Clin Res; 1987; 13(8):497-500. PubMed ID: 3428132
[TBL] [Abstract][Full Text] [Related]
84. In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia.
Wang E; Simard M; Bergeron Y; Beauchamp D; Bergeron MG
Antimicrob Agents Chemother; 2000 Apr; 44(4):1010-8. PubMed ID: 10722505
[TBL] [Abstract][Full Text] [Related]
85. Therapeutic efficacy of meropenem for treatment of experimental penicillin-resistant pneumococcal meningitis.
Kim SW; Jin JH; Kang SJ; Jung SI; Kim YS; Kim CK; Lee H; Oh WS; Kim S; Peck KR; Song JH
J Korean Med Sci; 2004 Feb; 19(1):21-6. PubMed ID: 14966336
[TBL] [Abstract][Full Text] [Related]
86. Effects of EDP-420 on penicillin-resistant and quinolone- and penicillin-resistant pneumococci in the rabbit meningitis model.
Stucki A; Gerber P; Acosta F; Cottagnoud M; Cottagnoud P; Jiang L; Nguyen P; Wachtel D; Wang G; Phan LT
J Antimicrob Chemother; 2008 Mar; 61(3):665-9. PubMed ID: 18222952
[TBL] [Abstract][Full Text] [Related]
87. [Clinical and experimental rifampicin passage through the hemato-encephalic barrier and its effectiveness in treating meningococcal infections].
Ivanov KS; Verovaia AV; Dergunova GA; Duiunov VM; Popova NN
Antibiotiki; 1981 May; 26(5):383-8. PubMed ID: 7259147
[TBL] [Abstract][Full Text] [Related]
88. Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis.
Nau R; Wellmer A; Soto A; Koch K; Schneider O; Schmidt H; Gerber J; Michel U; Brück W
J Infect Dis; 1999 Jun; 179(6):1557-60. PubMed ID: 10228082
[TBL] [Abstract][Full Text] [Related]
89. Gentamicin increases the efficacy of vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.
Cottagnoud P; Gerber CM; Cottagnoud M; Täuber MG
Antimicrob Agents Chemother; 2002 Jan; 46(1):188-90. PubMed ID: 11751132
[TBL] [Abstract][Full Text] [Related]
90. A new twist on an old problem: a case of pediatric meningitis caused by multidrug-resistant Streptococcus pneumoniae serotype 19A.
Ciccotelli W; Poutanen S; Morris S; Alqahtani M; Cox P; Low D; Pillai D; Opavsky M
Can Commun Dis Rep; 2008 Nov; 34(11):1-6. PubMed ID: 19051388
[TBL] [Abstract][Full Text] [Related]
91. Meropenem susceptibility of Neisseria meningitidis and Streptococcus pneumoniae from meningitis patients in The Netherlands.
van de Beek D; Hensen EF; Spanjaard L; de Gans J; Enting RH; Dankert J
J Antimicrob Chemother; 1997 Dec; 40(6):895-7. PubMed ID: 9462445
[TBL] [Abstract][Full Text] [Related]
92. [Alternating rifampicin and ceftriaxone for Neisseria meningitidis eradication in contacts].
Shehab S; Leitner L; Bogokowsky B; Epstein I; Swartz TA
Harefuah; 1991 Jun; 120(11):641-3. PubMed ID: 1937208
[TBL] [Abstract][Full Text] [Related]
93. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
Gosbell IB; Fernandes LA; Fernandes CJ
Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
[TBL] [Abstract][Full Text] [Related]
94. [An adult case of bacterial meningitis caused by penicillin-resistant streptococcus pneumoniae].
Igeta Y; Ishiguro K; Okamoto K
Rinsho Shinkeigaku; 2004 Mar; 44(3):154-9. PubMed ID: 15233266
[TBL] [Abstract][Full Text] [Related]
95. Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci.
Rodriguez-Cerrato V; McCoig CC; Saavedra J; Barton T; Michelow IC; Hardy RD; Bowlware K; Iglehart J; Katz K; McCracken GH
Antimicrob Agents Chemother; 2003 Jan; 47(1):211-5. PubMed ID: 12499193
[TBL] [Abstract][Full Text] [Related]
96. [Ceftriaxone-resistant Streptococcus pneumoniae meningitis: case report].
Saavedra-Velasco M; Tapia-Cruz M; Grandez-Urbina JA; Zegarra Del Rosario-Alvarado S; Mendo-Urbina F; Pichardo-Rodriguez R
Rev Peru Med Exp Salud Publica; 2019; 36(2):349-352. PubMed ID: 31460651
[TBL] [Abstract][Full Text] [Related]
97. Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis.
Cottagnoud P; Pfister M; Cottagnoud M; Acosta F; Täuber MG
Antimicrob Agents Chemother; 2003 Jun; 47(6):1943-7. PubMed ID: 12760871
[TBL] [Abstract][Full Text] [Related]
98. Diagnostic challenges with acellular bacterial meningitis.
Moolla Y; Naidoo L
S Afr Med J; 2016 Sep; 106(10):988-989. PubMed ID: 27725017
[TBL] [Abstract][Full Text] [Related]
99. The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s.
Bradley JS; Scheld WM
Clin Infect Dis; 1997 Feb; 24 Suppl 2():S213-21. PubMed ID: 9126696
[TBL] [Abstract][Full Text] [Related]
100. Antibiotic resistance. A vancomycin surprise.
Gilmore MS; Hoch JA
Nature; 1999 Jun; 399(6736):524-5, 527. PubMed ID: 10376590
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
